Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.
Open Access
- 1 January 1980
- journal article
- Published by Wiley
- Vol. 9 (1) , 91-94
- https://doi.org/10.1111/j.1365-2125.1980.tb04802.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites : Its application for pharmacokinetic studies with salicylazosulfapyridine in manJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1978
- Therapeutic Drug Monitoring in SalivaClinical Pharmacokinetics, 1978
- Salivary excretion and pharmacokinetics of sulfapyridine after sulfasalazineClinical Pharmacology & Therapeutics, 1977
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976
- Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine.1973
- THE BINDING OF SULFONAMIDE DRUGS BY PLASMA PROTEINS. A FACTOR IN DETERMINING THE DISTRIBUTION OF DRUGS IN THE BODYJournal of Clinical Investigation, 1943